Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Glenda Nicioli da Silva
Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Related publications
MiR-34a Chemosensitizes Bladder Cancer Cells to Cisplatin Treatment Regardless of P53-Rb Pathway Status
International Journal of Cancer
Cancer Research
Oncology
1,25D3 Enhances Antitumor Activity of Gemcitabine and Cisplatin in Human Bladder Cancer Models
Cancer
Cancer Research
Oncology
The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells
Cisplatin and Gemcitabine With Either Vinorelbine or Paclitaxel in the Treatment of Carcinomas of Unknown Primary Site
Cancer
Cancer Research
Oncology
Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced and or Metastatic Bilharzial Urothelial Carcinoma of the Bladder in Egypt.
Research in Oncology
Efficacy of Neoadjuvant Gemcitabine and Cisplatin in the Management of Muscle-Invasive Urothelial Carcinoma of the Bladder
Japanese Journal of Urology
Urology
TP53 Codon 72 Polymorphism Is Associated With FGFR3 and RAS Mutation in Non-Muscle-Invasive Bladder Cancer
PLoS ONE
Multidisciplinary
Sphingosine Induces Apoptosis and Down-Regulation of MYCN in PAX3–FOXO1-positive Alveolar Rhabdomyosarcoma Cells Irrespective of TP53 Mutation
Anticancer Research
Medicine
Cancer Research
Oncology
